Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,051 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

NCT00730639

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +34 more
Locations
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

NCT01472081

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • City Of Hope Duarte, California, United States
  • Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 14 locations
View Trial Details
Completed

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

NCT00550277

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Baton Rouge General Medical Center Baton Rouge, Louisiana, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
View Trial Details
Completed

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

NCT03319459

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • The Ohio State University James Cancer Hospital Columbus, Ohio, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View Trial Details
Completed

Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment

NCT02789137

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Hospital Arquitecto Marcide de Ferrol Ferrol, A Coruña, Spain
  • Hospital Asil de Granollers Granollers, Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • Hospital Galdakano Usansolo, Bizkaia, Spain
View all 23 locations
View Trial Details

Related conditions